These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
84 related items for PubMed ID: 9064437
1. [Adult height, pattern of growth and pubertal development in patients with congenital adrenal hyperplasia, salt losing form]. Gussinyé M, Potau N, Vicens-Calvet E, Albisu MA, Yeste D, Ibáñez L, Audí L, Carrascosa A. Med Clin (Barc); 1997 Jan 25; 108(3):87-90. PubMed ID: 9064437 [Abstract] [Full Text] [Related]
2. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens. Rasat R, Espiner EA, Abbott GD. N Z Med J; 1995 Aug 11; 108(1005):311-4. PubMed ID: 7644165 [Abstract] [Full Text] [Related]
3. [Puberty and growth development in patients with a 21-hydroxylase defect]. Börger D, Willig RP. Monatsschr Kinderheilkd; 1985 Nov 11; 133(11):828-33. PubMed ID: 2934617 [Abstract] [Full Text] [Related]
4. Effect of the dose of oral hydrocortisone on growth rate during long-term treatment of children with salt losing congenital adrenal hyperplasia. Ciaccio M, Montiveros C, Rivarola MA, Belgorosky A. Medicina (B Aires); 2002 Nov 11; 62(6):551-4. PubMed ID: 12532689 [Abstract] [Full Text] [Related]
5. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Völkl TM, Simm D, Beier C, Dörr HG. Pediatrics; 2006 Jan 11; 117(1):e98-105. PubMed ID: 16396852 [Abstract] [Full Text] [Related]
6. [Puberty and adult height in congenital virilizing adrenal hyperplasia (author's transl)]. Himon F, Job JC, Pierson M, Canlorbe P. Sem Hop; 2006 Jan 11; 57(37-38):1488-93. PubMed ID: 6270813 [Abstract] [Full Text] [Related]
7. Age of pubertal onset affects the intensity and duration of pubertal growth peak but not final height. Vizmanos B, Martí-Henneberg C, Clivillé R, Moreno A, Fernández-Ballart J. Am J Hum Biol; 2001 Jan 11; 13(3):409-16. PubMed ID: 11460907 [Abstract] [Full Text] [Related]
8. [Value of the assay of plasma steroids in the control of congenital adrenal hyperplasia]. Theintz GE, Sizonenko PC. Arch Fr Pediatr; 1985 Mar 11; 42(3):211-7. PubMed ID: 4004483 [Abstract] [Full Text] [Related]
9. Variations in duration of pubertal growth: a mechanism compensating for differences in timing of puberty and minimizing their effects on final height. Belgian Study Group for Paediatric Endocrinology. Bourguignon JP. Acta Paediatr Scand Suppl; 1988 Mar 11; 347():16-24. PubMed ID: 3254030 [Abstract] [Full Text] [Related]
10. The natural history of premature adrenarche. Ghizzoni L, Milani S. J Pediatr Endocrinol Metab; 2000 Mar 11; 13 Suppl 5():1247-51. PubMed ID: 11117663 [Abstract] [Full Text] [Related]
11. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C. Clin Endocrinol (Oxf); 2002 Nov 11; 57(5):669-76. PubMed ID: 12390343 [Abstract] [Full Text] [Related]
12. Final height of patients with classical congenital adrenal hyperplasia. Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P. Turk J Pediatr; 2009 Nov 11; 51(6):539-44. PubMed ID: 20196386 [Abstract] [Full Text] [Related]
13. [Pubertal growth, final height and weight gain in girls diagnosed with IDDM during pre-pubertal period]. Roldán Martín MB, Escobar-Morreale H, Alonso Blanco M, Barrio Castellanos R. An Esp Pediatr; 1999 Nov 11; 51(5):493-8. PubMed ID: 10652800 [Abstract] [Full Text] [Related]
14. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia. Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K. J Pediatr; 2015 Mar 11; 166(3):743-50. PubMed ID: 25557963 [Abstract] [Full Text] [Related]
15. Early puberty-menarche after precocious pubarche: relation to prenatal growth. Ibáñez L, Jiménez R, de Zegher F. Pediatrics; 2006 Jan 11; 117(1):117-21. PubMed ID: 16396868 [Abstract] [Full Text] [Related]
16. Factors predicting final height in early treated congenital hypothyroid patients. Delvecchio M, Salerno M, Acquafredda A, Zecchino C, Fico F, Manca F, Faienza MF, Cavallo L. Clin Endocrinol (Oxf); 2006 Nov 11; 65(5):693-7. PubMed ID: 17054475 [Abstract] [Full Text] [Related]
17. [Growth and puberal development in males with adreno-genital syndrome]. Gargantini L, Calzi P, Brunelli V, Braggion F, Chiumello G. Pediatr Med Chir; 1989 Nov 11; 11(6):597-602. PubMed ID: 2699925 [Abstract] [Full Text] [Related]
18. Children born small for gestational age (SGA) who fail to achieve catch up growth by 2-8 years of age are short from infancy to adulthood. Data from a cross-sectional study of 486 Spanish children. Carrascosa A, Vicens-Calvet E, Yeste D, Espadero RM, Ulied A, SGA Spanish Collaborative Group. Pediatr Endocrinol Rev; 2006 Sep 11; 4(1):15-27. PubMed ID: 17021579 [Abstract] [Full Text] [Related]
19. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation. Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP. J Clin Endocrinol Metab; 2009 Oct 11; 94(10):3882-8. PubMed ID: 19622620 [Abstract] [Full Text] [Related]
20. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort. Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group. J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]